Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Tolerance of Natroba in Pediatric Head Lice
NCT01660321Phase 4Completed
- Sponsor
- ParaPRO
- Start
- Sep 2011
- Primary completion
- Oct 2011
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of spinosad in pediculosis capitis, sponsored by ParaPRO. Primary endpoints: Maximum Plasma Concentration (Cmax) for Spinosyn A at 12 hours, Time to Maximum Plasma Concentration (Tmax) for Spinosyn A at 12 hours and 7 more. Started Sep 2011; status: completed.
02
Drugs
spinosad
03
Conditions
pediculosis capitis
Beyond the preview
Go deeper on NCT01660321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01660321.